In silico analysis predicts biological activity and pharmacokinetic properties of nitronorbornene analogs, suggesting potential pharmacological applications.
Selected nitronorbornene analogs bearing different substituents were analyzed using in silico methods to predict their biological and pharmacokinetic properties. The compounds demonstrated potential biological activity, as indicated by PASS predictions, and exhibited favorable ADME profiles based on SWISS ADME analysis. These findings highlight their promise as candidates for further experimental evaluation and potential pharmacological applications.
No takes yet. Share an insight, caveat, or question.
Kruczyński et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: